{
    "nct_id": "NCT05236062",
    "official_title": "Impact of Exercise on the Complications of Corticosteroids in Patients With Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation: the RESTART Trial",
    "inclusion_criteria": "* Over 18 years old; children under the age of 18 will be excluded due to rarity of disease\n* Newly diagnosed with acute or chronic GVHD, starting corticosteroids at a dose of 1 mg/kg or greater for the first time since transplant\n* Received allogeneic stem cell transplant (any conditioning, any donor) at Dana-Farber Cancer Institute\n* Physician's clearance to participate in moderate-vigorous intensity exercise\n* Speak English\n* Currently participate in less than 60 minutes of structured exercise/week\n* Willing to travel to Dana-Farber Cancer Institute for necessary data collection\n* Ability to understand and the willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Have a plan for hospital admission within the next 13 weeks at the time of recruitment\n* If patients are not enrolled within 7 days after initial steroid treatment, they will be ineligible\n* Pre-existing musculoskeletal or cardiorespiratory conditions\n* Patients should not have any uncontrolled illness including ongoing or active infection, uncontrolled diabetes, hypertension, or thyroid disease\n* Patients may not be receiving any other investigational agents, or concurrent biological, chemotherapy, or radiation therapy\n* Patients with other active malignancies\n* Participate in more than 60 minutes of structured exercise/week\n* Unable to travel to Dana-Farber Cancer Institute for necessary data collection\n* Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.",
    "miscellaneous_criteria": ""
}